Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternation of FOLFOX6 and FOLFIRI in Second Line Metastatic Colorectal Cancer
NCT00006115Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Apr 1999
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, irinotecan, fluorouracil, folinic acid in colorectal cancer (CRC), sponsored by GERCOR. Status: unknown.
02
Drugs
oxaliplatinirinotecanfluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00006115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006115.